Skip to Content

Aptose Biosciences Inc

Rating as of

Company Profile

Business Description

Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.

251 Consumers Road, Suite 1105
Toronto, ON, M2J 4R3, Canada
T +1 650 718-5028
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2019
Stock Type
Employees 31